Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
ICG165
/
iCell Gene Therap
Welcome,
Profile
Billing
Logout
Diseases
Trials
Trials
News
||
||||||||
ICG165
/
iCell Gene Therap
New P1 trial, CAR T-Cell Therapy:
Anti-CD33 CAR-T Cells for the Treatment of Relapsed/Refractory CD33+ Acute Myeloid Leukemia
(clinicaltrials.gov) - Jul 5, 2022
P1
, N=10, Not yet recruiting,
Sponsor: iCell Gene Therapeutics